The Joint Clinical Assessment (JCA) process in the European Union marks a significant advancement in
France’s Reimbursed Early Access Programs (EAPs) allow for reimbursement of new medicines before traditional reimbursement
The Haute Autorité de Santé (HAS) has recently shared a two-year summary of its Early
In an effort to control rising cost Germany introduced both a price freeze preventing price
Justin Stindt Consultants is a fast growing consulting company offering strategy & market access consulting services to leading pharmaceutical, biotech and medical device clients. We operate in Europe and the United States.
